Abstract
Purpose: To describe the results obtained with intravitreal ranibizumab injections in a patient with adult onset foveomacular vitelliform dystrophy (AOFVD) complicated by Type 3 choroidal neovascularization (CNV). Methods: A 78-year old man diagnosed with AOFVD presented at our department for decreased vision in his left eye (LE) (20/80). Upon a complete ophthalmologic examination, including fluorescein angiography, indocyanine green angiography, and spectral-domain optical coherence tomography, the patient was diagnosed with Type 3 CNV. Three monthly injections of ranibizumab 0.05 ml/0.5 mg were administered intravitreally without complications. Results: After the first injection, visual acuity of the LE improved (20/64) and regression of the Type 3 CNV was observed by fluorescein angiography, indocyanine green angiography and OCT. Six months after the final ranibizumab injection, a more-or-less complete resolution of the exudative retinal changes was observed. Conclusions: Type 3 CNV may be associated with AOFVD. Intravitreal ranibizumab may represent a possible therapeutic option in this unusual context.
Original language | English |
---|---|
Journal | Journal Francais d'Ophtalmologie |
Volume | 36 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2013 |
Keywords
- Adult onset foveomacular vitelliform dystrophy
- Age-related macular degeneration
- Fluorescein angiography
- Indocyanine green angiography
- Lucentis
- Ranibizumab
- Retinal angiomatous proliferation
- Retinal-choroidal anastomosis
- Spectral-domain optical coherence tomography
- Type 3 choroidal neovascularization
- Vitelliform macular dystrophy
ASJC Scopus subject areas
- Ophthalmology